Detalhe da pesquisa
1.
Health economic analysis of patients treated with isavuconazole in a German comprehensive cancer centre.
Mycoses
; 66(5): 405-411, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-36670539
2.
Retrospective modelling of hospital bed capacities associated with the administration of remdesivir during the first wave of COVID-19 in a German metropolitan city.
J Antimicrob Chemother
; 77(3): 753-757, 2022 02 23.
Artigo
Inglês
| MEDLINE | ID: mdl-34849943
3.
A cost of illness study of COVID-19 patients and retrospective modelling of potential cost savings when administering remdesivir during the pandemic "first wave" in a German tertiary care hospital.
Infection
; 50(1): 191-201, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34406606
4.
Health economic analysis of third-line interventions in diffuse large B-cell lymphomas in Germany: applying the efficiency frontier.
Cost Eff Resour Alloc
; 20(1): 67, 2022 Dec 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36503527
5.
Prevalence and potential biological role of TERT amplifications in ALK translocated adenocarcinoma of the lung.
Histopathology
; 78(4): 578-585, 2021 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-32946634
6.
Reimbursement of innovative pharmaceuticals in English and Spanish hospitals-The example of isavuconazole.
Mycoses
; 64(10): 1213-1222, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-34134179
7.
A budget impact analysis of bezlotoxumab versus standard of care antibiotics only in patients at high risk of CDI recurrence from a hospital management perspective in Germany.
BMC Health Serv Res
; 21(1): 939, 2021 Sep 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34496836
8.
Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogies.
Mod Pathol
; 32(5): 627-638, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30459450
9.
Genetic instability and recurrent MYC amplification in ALK-translocated NSCLC: a central role of TP53 mutations.
J Pathol
; 246(1): 67-76, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29885057
10.
An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations.
Adv Ther
; 40(3): 1187-1203, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36652175
11.
Last Resort Antibiotics Costs and Reimbursement Analysis of Real-Life ICU Patients with Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacteria in Germany.
Healthcare (Basel)
; 10(12)2022 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36554068
12.
Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications.
Lung Cancer
; 168: 10-20, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35461051
13.
Genetic Heterogeneity of MET-Aberrant NSCLC and Its Impact on the Outcome of Immunotherapy.
J Thorac Oncol
; 16(4): 572-582, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33309988
14.
Economic Impact of the Introduction of Outpatient Medical Specialist Care (ASV) of Gastrointestinal Cancer Patients from a German Hospital Management Perspective.
Oncol Res Treat
; 43(10): 498-505, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32957103
15.
Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutations.
Lung Cancer
; 144: 40-48, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32361034
16.
Plerixafor in non-Hodgkin's lymphoma patients: a German analysis of time, effort and costs.
Bone Marrow Transplant
; 54(1): 123-129, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29795422
17.
Advance of theragnosis biomarkers in lung cancer: from clinical to molecular pathology and biology.
J Thorac Dis
; 11(Suppl 1): S3-S8, 2019 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-30775023
18.
The economic burden of endoscopic treatment for anastomotic leaks following oncological Ivor Lewis esophagectomy.
PLoS One
; 14(8): e0221406, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31461487
19.
Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial.
J Thorac Oncol
; 14(7): 1266-1276, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30978502
20.
K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways.
J Thorac Oncol
; 14(4): 606-616, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30605727